Clinical investigators provide concise comments on the efficacy and safety of PARP inhibitors and novel agents in the management of ovarian cancer. Featuring perspectives from Drs Robert A Burger, Jonathan A Ledermann, Joyce F Liu, Mansoor Raza Mirza, Kathleen Moore, David M O’Malley, Richard T Penson and Robert M Wenham.
Clinical investigators provide concise comments on therapy for patients with ovarian cancer at later-line platinum-sensitive relapse. Featuring perspectives from Drs Robert A Burger, Jonathan A Ledermann, Joyce F Liu, Mansoor Raza Mirza, Kathleen Moore, David M O’Malley, Richard T Penson and Robert M Wenham.
Clinical investigators provide concise comments on therapy for patients at first platinum-sensitive relapse. Featuring perspectives from Drs Robert A Burger, Jonathan A Ledermann, Joyce F Liu, Mansoor Raza Mirza, Kathleen Moore, David M O’Malley, Richard T Penson and Robert M Wenham.
Clinical investigators provide concise comments on therapy for patients with newly diagnosed ovarian cancer. Featuring perspectives from Drs Robert A Burger, Jonathan A Ledermann, Joyce F Liu, Mansoor Raza Mirza, Kathleen Moore, David M O’Malley, Richard T Penson and Robert M Wenham.
